Patients with Morgellons disease have a lower quality of life than patients with psoriasis, atopic dermatitis and prurigo nodularis

Morgellons disease (MD) greatly affects a patient’s quality of life (QoL). Therefore, we aimed to measure the disease burden of MD on QoL and compare it with well-funded dermatological conditions, including prurigo nodularis (PN), atopic dermatitis (AD) and psoriasis. This qualitative cross-sectiona...

Full description

Saved in:
Bibliographic Details
Published in:British journal of dermatology (1951) 2024-09
Main Authors: Gipple, Mackenzie O, Dhami, Ramneek K, Latour, Emile, Keller, Jesse J
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Morgellons disease (MD) greatly affects a patient’s quality of life (QoL). Therefore, we aimed to measure the disease burden of MD on QoL and compare it with well-funded dermatological conditions, including prurigo nodularis (PN), atopic dermatitis (AD) and psoriasis. This qualitative cross-sectional survey, comprising Dermatology Life Quality Index (DLQI), Pittsburgh Sleep Quality Index (PSQI) and 5-D itch scale questionnaires, was distributed to patients with untreated MD seen at the Oregon Health and Science University Dermatology clinic from July 2022 to July 2023. When comparing mean scores across dermatological conditions, MD had significantly higher DLQI scores than PN, AD and psoriasis, and significantly higher PSQI scores than AD and psoriasis.
ISSN:0007-0963
1365-2133
DOI:10.1093/bjd/ljae335